SanBio Company Limited (OTCMKTS:SNBIF) Short Interest Update

SanBio Company Limited (OTCMKTS:SNBIF) saw a significant decline in short interest in the month of April. As of April 15th, there was short interest totalling 443,500 shares, a decline of 15.4% from the March 31st total of 524,500 shares. Based on an average trading volume of 200 shares, the days-to-cover ratio is currently 2,217.5 days.

SanBio Price Performance

OTCMKTS:SNBIF opened at C$11.32 on Friday. SanBio has a 52 week low of C$4.65 and a 52 week high of C$11.32. The firm’s 50-day simple moving average is C$8.55 and its 200 day simple moving average is C$6.04.

SanBio Company Profile

SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, Parkinson’s disease, spinal cord injury, and Alzheimer’s disease; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis.